Introduction {#Sec1}
============

The responsible development of nanotechnology is a goal of many organizations worldwide (e.g. Royal Society and Royal Academy of Engineering [@CR129]; NIOSH [@CR92]; Jacobstein [@CR60]; CEST [@CR23]; Tomellini and Giordani [@CR152]; Luigi [@CR73]; Nanocyl [@CR86]; NNI [@CR102]; Forloni [@CR39]; VCI [@CR158]; BASF [@CR7]; BIAC [@CR20]). Ideally, the concept of responsible development of nanotechnology implies that there are criteria against which to evaluate development. The focus of those criteria is the prevention of harm to people, and the environment. Workers are the first people exposed to the potential hazards of any new technology including nanotechnology, since they are involved in the research, development, manufacture, production, use, recycling, and disposal of nanomaterials or products containing nanomaterials. Workers often have the highest exposure, which may occur early in the development of a technology when hazards and risks are uncertain. If exposure to nanomaterials harms workers, then nanotechnology is not being responsibly developed. For these reasons, occupational safety and health is the cornerstone of responsible nanotechnology development (Maynard and Kuempel [@CR76]; Schulte and Salamanca-Buentello [@CR138]; Seaton et al. [@CR146]). Anticipating and preventing harm to consumers from products containing nanomaterials is also part of responsible development, as is anticipating how nanomaterials might adversely impact the environment.

There is a moral imperative for worker protection which is of paramount importance, i.e., workers have rights to a safe work environment (Gewirth [@CR41]). Thus, safety of work was recognized as a basic human right by the 2008 Seoul Declaration on Safety and Health at Work (ILO [@CR53]). These rights bring commensurate responsibilities for employers and government authorities to protect workers from harm as fully as is reasonably possible. These responsibilities have been codified in laws and regulations such as the Occupational Safety and Health (OSH) Act, the Mine Safety and Health (MSH) Act, the Toxic Substances Control Act (TSCA) in the United States, and similar legislation and guidance worldwide (e.g., WHO [@CR160]; BAuA [@CR8]; Nanosafe [@CR87]; ISO [@CR59]; Japan NIOSH [@CR93]; Pelley and Saner [@CR116]; Bayer [@CR10]; Murashov et al. [@CR81]; Nakanishi [@CR83], [@CR84]).

Underlying the criteria for responsible development of nanotechnology is the need to be proactive in taking steps to limit exposure of workers, consumers, and the environment to nanomaterials before actual risks are fully understood (Kreider and Halperin [@CR64]). These criteria are not new, but build on basic OSH principles that should be applied to nanotechnology at the early stages in its development. While evidence-based risk assessment and management are the ideals, often action must be taken with less than strong evidence. Moreover, the ultimate component of responsible development is to reduce hazards and risks to the extent feasible and to communicate with, and engage, affected parties (workers) in the management of risks. In this article, the occupational safety and health criteria for responsible development of nanotechnology are defined and their implications are described. These criteria can be considered at the business enterprise and societal levels. Ideally, the criteria would be developed at the societal level (by government agencies, trade, and professional associations, unions, non-governmental organizations (NGOs), insurers, scientists) first and then promoted for use at the business enterprise level (employers, suppliers, business customers). In reality, nanotechnology products were in commerce before criteria for responsible development were in place. That does not mean that there were no applicable societal expectations. The whole history of societal response to hazardous materials provided a framework to initially address the products of nanotechnology. Already in place, as mandated by the OSH Act of 1970 (Public Law 91--596) in the United States, as well as guidance developed by other countries and organizations (e.g., EU Directive 89/336/EEC and Directive 98/21/EC), was the concept that the employer must provide a safe and healthy workplace. Definitions of "safe" and "healthy" for nanomaterials build on experience gained in the 20th century on addressing worker hazards and risks from exposure to fine dusts and powders in various industries such as pigment, pharmaceutical, nuclear, and pesticide manufacturing (Higgins [@CR47]; Dressen et al. [@CR30]; Cook [@CR26]; Sargent and Kirk [@CR133]; Maiello and Hoover [@CR74]). Also, in place were validated risk management practices for controlling fine dusts and powders coming out of the fields of aerosol science, industrial hygiene, exposure assessment, toxicology, and engineering (Hinds [@CR48]).

A body of knowledge developed over the past 100 years shows that small particles can, on an equal mass basis, be more hazardous than larger ones (Driscoll [@CR31]; IOM [@CR57]; Zhang et al. [@CR163], [@CR164]; Brown et al. [@CR18]; Duffin et al. [@CR32]; Oberdörster et al. [@CR108]; Seaton et al. [@CR146]). Thus, it was known, before, engineered nanomaterials entered commerce that incidental nanoparticles (e.g., welding and diesel fumes) could be carcinogenic when inhaled (Oberdörster and Yu [@CR105]; Heinrich et al. [@CR45]; Antonini [@CR5]); that small aerosol pollutants were linked to respiratory and cardiovascular risks (Dockery et al. [@CR29]; Pope et al. [@CR121]); and that certain "legacy produced" nanomaterials such as ultrafine titanium dioxide, carbon black, and fumed silica were respiratory hazards (Reuzel et al. [@CR123]; Oberdörster et al. [@CR106]; Gardiner et al. [@CR40]; Merget et al. [@CR78]). Clearly too, there also was extensive literature that larger (microscale) inhaled particles are known respiratory hazards (e.g., silica, coal dust) (NIOSH [@CR91], [@CR97]). The relationship between particle lung dose and adverse lung effects (e.g., pulmonary inflammation or lung tumors in rats) has been observed to be nonlinear for poorly-soluble low toxicity particles, with no clear particle size threshold (NIOSH [@CR98]). Nonetheless, for many decision-makers at the business or societal levels, how to define the responsible approach for the safe development of engineered nanomaterials was unclear; and, in some cases, it remains so today, in the second decade of commercialization. This is despite the fact that precautionary guidance has been promulgated by authorities since the mid-2000s (EU-OSHA [@CR36]; Roco and Bainbridge [@CR127]; Hett [@CR46]; HSE [@CR51]; NNI [@CR101]; NIOSH [@CR92]; SCENIHR [@CR135]; ISO [@CR58]; Safe Work Australia [@CR130]; OSHA [@CR112]).

Criteria for responsible development {#Sec2}
====================================

Five criterion actions (Table [1](#Tab1){ref-type="table"}) may be considered that demonstrate responsible development from an occupational safety and health perspective. These include: (1) anticipate, identify, and track potentially hazardous nanomaterials in the workplace; (2) assess workers' exposures to nanomaterials; (3) assess and communicate hazards and risks to workers; 4) manage occupational safety and health risks; and (5) foster the safe development of nanotechnology and the realization of its societal and commercial benefits. These criteria can be assessed at the business enterprise and societal levels. They are based on various influences, including the history of occupational safety and health in the 20th century; the anticipatory work of various researchers and officials (Ashford [@CR6]; Samuels [@CR132]; Colvin [@CR25]; Roco [@CR126]; Aitken et al. [@CR2]; Maynard and Kuempel [@CR76]; Maynard [@CR75]; Murashov and Howard [@CR79]; Tomellini and Giordani [@CR152]; Howard [@CR49]; Roco et al. [@CR128]; Murashov and Howard [@CR80]); the ethical framework described by Schulte and Salamanca-Buentello ([@CR138]); and the practices of governmental agencies \[e.g., the National Institute for Occupational Safety and Health (NIOSH)\], corporations, and labor organizations worldwide conducting research or developing risk management guidance. The criteria also build on the 1983 and 2009 risk assessment paradigms by the U.S. National Research Council (NRC [@CR103]) of the National Academies of Science; the Rio Conference of 1992 (UN [@CR155]); the reports by the National Academy of Engineering ([@CR88]) and the Royal Society and Royal Academy of Engineering ([@CR129]); the principles of tiered toxicological screening (Oberdörster et al. [@CR107]); and the Nano Risk Framework ([@CR85]).Table 1Occupational safety and health criteria that demonstrate responsible development of nanotechnologyCriteriaBusiness enterprise responsibilitySocietal responsibilityAnticipate, identify, and track potentially hazardous nanomaterials in the workplaceIdentify nanomaterials in the workplace\
Conduct toxicologic research\
Take precautionary (prudent) approachesIssue anticipatory guidance\
Conduct toxicologic research\
Issue hazard guidance and controlAssess workers\' exposures to nanomaterialsMeasure exposureProvide guidance on metrics, sampling methods, and analysisAssess and communicate hazards and risks to workersConduct hazard and risk assessments\
Communicate hazard and risk information to workers\
Train workers in safe handling techniquesConduct hazard and risk assessments, including quantitative estimates\
Communicate risk information to employers, unions, workers, other agencies, and the publicManage occupational safety and health risksManage workplace risks from nanomaterials\
 Control exposures\
 Monitor workers exposure and healthInclude many partners to develop governance strategies\
Issue guidance on workplace risk management\
 OELs (occupational exposure limits)\
 Engineering controls and PPE (personal protective equipment)\
 Medical surveillanceFoster the safe development of nanotechnology and the realization of societal and commercial benefitsProtect workers from any harm from nanomaterials\
Convey the degree of uncertainty known about risks\
Acknowledge hazards\
Support precautionary approaches\
Document the effectiveness of controlsConvey the degree of certainty about hazards and risks\
Conduct research to address uncertainties\
Demonstrate the effectiveness of controls\
Address relationship between occupational and environmental hazards\
Work globally\
Support education and scientific literacy

Integration of knowledge from all these related criteria is important, because (Fig. [1](#Fig1){ref-type="fig"}; Table [2](#Tab2){ref-type="table"}) actions under one criterion may influence actions under the others (European Commission [@CR37]; Kuempel et al. [@CR66]; Savolainen [@CR134]). Hazard information generally will drive much of the downstream actions, but each criterion can influence all the others. Responsible development requires integrated action among decision-makers addressing each criterion. At the business level, this may include activities of employers along the supply and value chains, and lifecycle of products. At the societal level, this can include activity of regulators, trade and professional associations, insurers, and NGOs, in endeavors supporting each criterion and all of them taken together.Fig. 1Interrelation of criteria for responsible development of nanotechnologyTable 2Relationship between occupational safety and health criteria for responsible development of nanotechnologyRelationship^a^Implications1.^b^HI ↔ EAProvides priorities for exposure assessment2.EA ↔ RAComponent factor in risk assessment provides priorities for exposure assessment3.RA ↔ RMInforms risk management4.RM ↔ FBMinimizes worker risks and enhances societal acceptance5.HI ↔ RAComponent factor in risk assessment; provides priorities for toxicology study6.HI ↔ RMTriggers risk management7.HI ↔ FBIdentifying worker hazards useful for identifying consumer and environmental hazards8.EA ↔ RMAssessing exposures is critical in controlling them9.EA ↔ FBIdentifying risk of exposures to workers provides information needed for effective risk management10.RA ↔ FBTrue depiction of risks and risk management decisions to minimize risk enhances societal acceptance^a^ *HI* hazard identification (anticipate, identify and track potentially hazardous nanomaterials in the workplace), *EA* exposure assessment (assess workers exposures to nanomaterial), *RA* risk assessment (assess and communicate hazards and risks to workers), *RM* risk management (manage occupational safety and health risks), *FB* foster benefits (foster the safe development of nanotechnology and the realization of societal and commercial benefits)^b^Number pertains to linkages in Fig. [1](#Fig1){ref-type="fig"}

The overarching driver in responsible development of nanotechnology and for each criterion is establishing responsibility for workplace safety and worker exposure. At the business level, the responsibility for a safe and healthy workplace is that of the employer. Early in the commercialization of nanotechnology, many employers indicated that they did not know much about the hazards, risk, exposure, and control of nanomaterials. This uncertainty about the hazards and risks could have resulted in many employers not undertaking the necessary responsibility to protect their workers (Ponce Del Castillo [@CR120]). This uncertainty about risks prompted government agencies to provide guidance on these issues. Workers and their representatives also have responsibilities to advocate for safe and healthy workplaces, to encourage and participate in risk management efforts at the business level, and to advocate for protective guidance at the societal level (CalOSHA [@CR21]; HSE [@CR52]). Society as a whole has the responsibility to support and empower employers, workers, unions, governments, and others in meeting their responsibilities. In addition, the public must be knowledgeable and engaged in deliberations considering new technologies, especially in regards to potential health risks that might be associated with this technology.

Anticipate, identify, and track potentially hazardous nanomaterials in the workplace {#Sec3}
------------------------------------------------------------------------------------

Due diligence and legal mandates require employers to be aware of hazards to which their employees could be exposed and all hazards present in facilities that they control (including nanomaterials as well as other chemical or physical hazards). When there is uncertainty about the nature, degree, and extent of hazards of nanomaterials, it is incumbent on employers to know what nanomaterials are in their workplaces, to identify processes where exposures can occur, and to support studies to determine the bioactivity of the nanomaterials. This is not always a simple matter for employers who might unknowingly be using intermediaries or product ingredients containing nanomaterials. Recent data have suggested that important information with regard to nanomaterials is not being included on current Safety Data Sheets (Safe Work Australia [@CR131]; Eastlake et al. [@CR33]; Lee et al. [@CR69]). In addition, with the advent and rollout of the globally harmonized system (GHS) of classification and labeling of chemicals, it is unclear how nanomaterials will be identified, classified, and labeled. Nevertheless, employers must consider the potential hazards of materials they manufacture or procure. When a concern exists, the employer should utilize existing exposure control guidance or seek expertise on implementing appropriate control measures. Critical to assessing the potential health risk to the material is the need to keep updated on new and changing hazard information.

At the societal level, anticipation and identification of hazards requires government agencies and other organizations to identify what nanomaterials are being widely made and used, their hazard potential, and how to control them (OECD [@CR110]; Safe Work Australia [@CR130]). This information needs to be communicated clearly and should describe the levels of certainty of the existing data and where there are gaps in the data. Government authorities and manufacturers are responsible for applying resources to test various nanomaterials, in order to better proscribe and issue hazard assessment and control guidance. Toxicological research is essential for responsible development of nanotechnology (Oberdörster et al. [@CR107]; Oberdörster et al. [@CR108]; Stone et al. [@CR149]). Toxicological research first showed that nanomaterials such as ultrafine titanium dioxide (TiO~2~) and carbon nanotubes (CNTs) can cause adverse respiratory effects in animals, indicating the potential to cause respiratory disease in workers (Heinrich et al. [@CR45]; Shvedova et al. [@CR148]; Dankovic et al. [@CR28]; Oberdörster et al. [@CR108]). This hazard identification was not an easy task. For example, with CNTs, the challenge was not merely to expose animals to atmospheres containing CNTs, but also to consistently generate aerosols of dimensions and characteristics in animal studies that had relevance to potential worker exposures (McKinney et al. [@CR77]).

Toxicological research is the basis for hazard identification. The responsible development of nanotechnology requires continued investment in such research. For due diligence under TSCA in the US or registration, evaluation, authorization, and restriction of chemical substances (REACH) in the European community, employers will need to continue to invest in toxicological research on nanomaterials. Linking toxicology testing to hazard determination is not new to the global chemical industry. Moving to the nanoscale has revealed new or heightened biological activity driven by size and physico-chemical properties, and employers will need to continue to explore the role of these parameters on toxicity. Better understanding of the correlation between physico-chemical properties and toxicity will facilitate assessment of hazards for new nanomaterials and the design of safer nanomaterials.

At the societal level, responsible development requires investment in toxicological assessment of widely used nanomaterials and in development of predictive models allowing estimation of hazards of new nanomaterials, as well as preventing particularly hazardous nanomaterials from entering into commerce (Oberdörster et al. [@CR107]; Xia et al. [@CR161]; Clark et al. [@CR24]; Bonner et al. [@CR14]; Winkler et al. [@CR159]). Such efforts also need to be accompanied by communication of hazards found in such assessments. Additionally, responsible development involves anticipating future nanomaterials development and applications for commercialization. This includes consideration of more complex and active nanomaterials (Subramanian et al. [@CR150]; Murashov et al. [@CR82]).

Standardized characterization criteria and validated assays and algorithms are needed to classify engineered nanomaterials by the nature and degree of hazard. Given the broad diversity of nanomaterial types, this will require basic research on what properties of nanomaterials can be linked to toxic effects. Tools to make categorical estimates of toxicity, such as various alternative testing strategies, quantitative structure--activity relationship (QSAR) models, computational toxicology, and bioinformatics, need to be applied to untested materials with similar properties and used as the basis for initial risk management decisions (Kuempel et al. [@CR67]; Nel et al. [@CR90]; Stone et al. [@CR149]).

Knowledge of hazards has been increased by international collaborations such as those supported by the Organisation for Economic Co-operation and Development (OECD), United States--European union bilateral efforts, World Health Organization (WHO), International Organization for Standardization (e.g., ISO TC 229), and the various agreements between nations. Participation in these collaborations is an important aspect of responsible development.

If correct decisions are to be made about hazards, risks, and control of nanomaterials, the scientific research needs to be conducted in these areas. Whereas, results from first-generation short-term toxicity testing were used to anticipate hazards from a small number of nanomaterials and implement exposure control measures, there is ultimately a need for standardized approaches for toxicological evaluation, setting priorities for toxicity testing, and long-term (chronic health effects) investigations (Oberdörster et al. [@CR107]; Savolainen [@CR134]; Bonner et al. [@CR14]; Stone et al. [@CR149]).

It is not informative enough to just identify hazards; there also is a need to know who is being exposed to them, at what exposure concentrations, and how exposure is affected by changes in job tasks. When the degree of hazard has not been ascertained, the general guidance of government agencies is to treat candidate nanomaterials in their workplaces as if they are potential hazards until a higher level of certainty about the presence or degree of hazard is available (Philbrick [@CR118]; Schulte et al. [@CR145]).

Assess workers' exposure to nanomaterials {#Sec4}
-----------------------------------------

Critical in assessing and managing risks is the measurement of exposures to nanomaterials (Ramachandran et al. [@CR122]). This is a complex endeavor, especially this early in the natural history of engineered nanomaterials, when what constitutes appropriate exposure metrics is not clear (Brouwer et al. [@CR17]; Ostraat et al. [@CR114]). Nonetheless, the earliest guidance has indicated that particle mass/volume of air can be a useful metric for measuring airborne exposures to nanomaterials. Since the first issuance of the "NIOSH Approaches to Safe Nanotechnology" at the NanOEH2 symposium in Minneapolis in 2005, government guidance on how to assess worker exposure and implement risk management strategies continues to be refined and updated as new information is obtained (NIOSH [@CR94]).

Assessing exposures in the workplace is the employer's responsibility, however, it is incumbent on government agencies and other organizations to assess in a general sense, the extent to which worker exposures are controlled and that guidance is provided on measurement approaches \[e.g., the European Union framework 7 nanodevice project (<http://www.nano-device.eu/index.php?id=123>)\]. The basis for this guidance, like that for identifying hazard potential, will be an evolving body of knowledge that should be continually evaluated. Continued efforts to identify hazards and determine workplace exposures are necessary to develop and update risk management guidance. Exposure is a critical factor that drives risk, and hence assessment and management of the risks. In order to minimize exposures, employers need to know and should assess what exposures actually occur, as well as their magnitude and background conditions. To adequately define occupational exposure to nanomaterials, information obtained by workplace environmental monitoring could be complemented by biological monitoring strategies that assess exposure by all routes.

Exposure assessment is important for other efforts that lead to responsible development of nanotechnology. These include helping to identify populations at risk, both in terms of actual exposures or exposure potential, and linking exposure to adverse effects in epidemiological studies (Schulte et al. [@CR142]; Dahm et al. [@CR27]; Riediker et al. [@CR124]). Exposure assessment data can also serve as a sampling frame for the formation of exposure registries (i.e., lists of workers with actual or potential exposure) that can be used in future epidemiologic and health surveillance studies. Exposure assessment data are also used in conducting risk assessments and in setting occupational exposure limits (OELs) (Schulte et al. [@CR143]). Sharing exposure data by making it publicly available would facilitate this task and should be considered a part of responsible development of nanotechnology.

Assess and communicate hazards and risks to workers {#Sec5}
---------------------------------------------------

Risk assessments by definition are evaluations to predict risks when adequate data are available, although complete data are often lacking. Risk assessments are based on various assumptions and may include a high degree of uncertainty. This is especially true for nanomaterials at this early stage in their development. Yet, when adequate data are available for risk analysis, it is prudent to use such data as the basis of initial risk management decisions, while identifying and acknowledging the uncertainties.

Ultimately, the type of risk management practices needed to protect workers will depend on the extent of the risks (Schulte and Ringen [@CR137]; Jonsen [@CR62]; NRC [@CR104]; Gibson et al. [@CR42]). Risk is a probabilistic concept that depends on both the hazard and the exposure. Characterizing the reliability and the uncertainty in risk estimates will be important in risk communication and management. Employers can perform qualitative risk assessments by identifying where and to what extent exposures to nanomaterials occur, or could occur among workers in their facilities. In addition, quantitative risk assessments (QRAs) allow for estimation of risks based on empirical data. For QRAs such as those conducted by authoritative organizations, the process includes the extrapolation of toxicology data from laboratory animal studies given the limited availability of epidemiological data. For airborne nanoparticles, this involves normalization of the lung burdens associated with adverse effects in animals to estimate the equivalent human lung burdens from worker exposure information (Kuempel et al. [@CR65]; [@CR67]).

Evaluating what data and information are needed to support decision-making is important in risk assessment. Although conducting QRAs on individual nanomaterials is useful, it is likely that adequate toxicological information on which to base the assessment will be available for only a small number of nanomaterials. Since there are currently many more nanomaterials than there is hazard or exposure information, it may be that risk assessment and the resulting exposure limits will focus on categories of nanomaterials (OECD [@CR109]; Kuempel et al. [@CR67]). A categorical approach allowing for a relatively rapid assessment of a large number of engineered nanomaterials will be especially useful in developing risk management policies in the early decades of nanotechnology commercialization.

While hazard communication to workers is codified in laws in some countries (OSHA [@CR111]), risk communication is less often included (HSA [@CR50]), but is an ethical responsibility based on the right-to-know (Yale Law Journal [@CR162]; Schulte and Ringen [@CR137]; Jonsen [@CR62]). The right of workers to know risk information is widely accepted and the duty of employers to communicate risk information derives from it. In some cases, explicit risk information is not available to employers, but there is information on components of risk---hazard and exposure. If employers communicate nanomaterial hazard and exposure information, they are conducting a basic form of risk communication. Hazard and risk communication related to nanomaterials are critical aspects of the responsible development of nanotechnology (CEST [@CR23]; Schulte and Salamanca-Buentello [@CR138]). Hazard and risk communication should be conducted by employers to nanomaterial workers, and also by manufacturers to their downstream users who may then use such information in their communications with workers.

It is not enough to merely assess risks; it is important that employers, government agencies, and other stakeholder organizations communicate what is known about the risks (Shatkin et al. [@CR147]). Ideally, risk communication should be two-directional rather than one-directional (Ponce del Castillo [@CR120]). The appropriate risk communication will depend on the risk perception of the intended audiences, particularly workers, and the extent to which they can participate in discussions of the risks and training about them (Kulinowski and Lippy [@CR68]). Risk communication and risk management are most effective when workers and employers are empowered to act on those risks.

Manage occupational safety and health risks {#Sec6}
-------------------------------------------

While employers are responsible for the management of risks, they often require guidance from authorities on appropriate risk management practices. This is especially true for nanomaterials, for which the knowledge base is limited and for small employers with limited expertise or resources. The general guidance from authorities has been to be aware of where nanomaterials are used and, as a precautionary measure, to control exposures as much as reasonably achievable. Early guidance from authorities was that free, unbound nanomaterials follow the laws of classic aerosol physics and that exposures can be controlled by the same approaches historically used for fine dusts, powders, and gases. As more knowledge was accrued, guidance included benchmark, provisional, or recommended single-substance exposure limits (BSI [@CR19]; Nakanishi [@CR84]; NIOSH [@CR98], [@CR99], [@CR100]; van Broekhuizen et al. [@CR157]). Other precautionary guidance came from applications of proposed and existing regulations to nanomaterials, such as, for manufacturers to submit risk management plans for carbon nanotubes under significant new use rules (SNUR) to the US Environmental Protection Agency (EPA) under TSCA (EPA [@CR35]). In addition, efforts to develop voluntary consensus standards for safe handling of nanomaterials in the workplace (e.g., ISO TC 229), were an early illustration of responsible development (ISO [@CR59]). It is the responsibility of employers to use the best available guidance as the basis for controlling exposures in the workplace (including training workers), and workers have the responsibility to cooperate with employers in carrying out risk management processes.

Various commentators have discussed the need for regulation of nanomaterials, similar to regulation of other workplace hazards (Pelley and Saner [@CR116]; Ling et al. [@CR71]; van Broekhuizen et al. [@CR157]). Regulations can be critical to the implementation of good risk management practices and a keystone for responsible development of nanotechnology (Murashov et al. [@CR81]). Although some existing general regulations may be considered to address nanomaterials, a good example of a specific approach is the recent international standard adopted in Canada for occupational exposure to engineered nanomaterials (Canadian Standards Association [@CR22]). Voluntary international standards can be a major force in the responsible development of nanotechnology and are more likely to be in place than specific national standards as evidenced by the ISO Standards on nanotechnology (Murashov and Howard [@CR79]; Murashov and Howard [@CR80]). Authoritative OSH recommendations from NIOSH and other agencies or organizations provide research and health-based criteria for promoting workplace health and safety (e.g., NIOSH [@CR94], [@CR98], [@CR99]).

The general basis for managing risks from hazards, including the potential hazards of nanomaterials, is to follow the hierarchy of controls (Peterson [@CR117]; NIOSH [@CR99], [@CR100]). One means of implementing the hierarchy of controls, in light of uncertainties about the hazards of nanomaterials, is by hazard and control banding approaches (Naumann et al. [@CR89]; NIOSH [@CR95]; Ostiguy et al. [@CR113]; Brouwer [@CR16]). Some efforts in this regard are already in effect, and their continued refinement is an important aspect of responsible development of nanotechnology (Paik et al. [@CR115]; ANSES [@CR4]). A hazard and control banding approach can be an alternative for controlling exposures when there is insufficient information for evidence-based OELs. Additionally, an important component of the application of control banding is verification of the performance and efficacy of controls for protecting workers' health (Jones and Nicas [@CR61]), as well as precaution in the application of these controls when health hazard data are limited (Schulte and Salamanca-Buentello [@CR138]).

The most effective level of the hierarchy of controls is to eliminate or design out hazards (Schulte et al. [@CR141]). This can be accomplished for some nanomaterials by modifying specific physico-chemical parameters of the material. The idea is that by modifying the functionality of the nanomaterials, the commercial utility of the material can be maintained while potential toxicity is reduced or mitigated. Various organizations and government agencies have been exploring this approach (<http://cnse.albany.edu/Outreach/NIOSHPresentations.aspx>). Responsible development of nanotechnology requires continued investment in this area.

At the societal level, responsible development of nanotechnology involves the development of national and international partnerships, and OELs. The US and the EU have supported biannual bilateral conferences on occupational safety and health issues beginning in 2009; nanotechnology was a focal topic (US--EU [@CR156]). In 2012, a set of overarching principles to guide research, guidance, legislation, and practice were developed under this US--EU partnership (Table [3](#Tab3){ref-type="table"}). The criteria described in this article are consistent with those principles.Table 3Overarching principles to guide research, guidance, legislation, and practice involving nanotechnologyThe health of workers should not be harmed by their work with nanomaterialsGlobally harmonized definitions for engineered nanomaterials are neededTransparency and traceability are essential to inform workers and employers if engineered nanomaterials are used in workplaces and where exposure may occurHazard and risk assessments must be performed to inform exposure control decisions for nanomaterials to which workers may be exposedEmerging and enabling nanotechnology should apply "safe by design" principles to materials and processes to engineer out the hazardous or toxic potentials of new engineered nanomaterials as a best practice to protect workers and the environmentEarly warning systems need to be developed to monitor workers' healthWell-established industrial hygiene practices are appropriate to address nanotechnology hazards and risksIf occupational exposure limit values are not available for specific nanomaterials, a precautionary approach should be appliedHarmonized exposure assessment measurements and control strategies need to be developed for nanomaterial processesWorkers have the right to participate in developing risk management practices involving nanomaterials in the workplaceAdapted from the draft US--EU 7th joint conference on occupational safety and health, topic 1: nanotechnology at the workplace, Brussels, 11--13 July 2012. <http://www.euusosh.org/>

Various organizations and authorities have published OELs for nanomaterials in terms of categorical, provisional, or specific values (BSI [@CR19]; NIOSH [@CR98], [@CR99], [@CR100]; van Broekhuizen et al. [@CR157]). In terms of regulatory frameworks, the promulgation of SNURs under TSCA by the EPA illustrates how employers can be required to address potential occupational safety and health concerns when using specific types of nanomaterials. Efforts to apply REACH provisions to nanomaterials are also under way. Ultimately, developing nanotechnology responsibly will require governments to work together and promote coordination and cooperation (Falkner and Jaspers [@CR38]).

Risk management programs (e.g., evaluation of exposures, implementation of exposure controls, training, medical surveillance) for nanomaterials should be seen as part of an overall occupational safety and health program for any company or workplace producing or using nanomaterials (Schulte et al. [@CR140]), including those along the supply and value chains. In addition, for nanomaterials, as for many other substances in production and use, there is limited hazard information and often there are no specific OELs. Responsible development of nanomaterials also includes consideration of nanomaterials in the context of managing other workplace hazards.

An important aspect of risk management is the medical surveillance of nanotechnology workers (NIOSH [@CR96]). Medical surveillance allows for the identification of workers who exhibit signs and systems of adverse effects resulting from exposures to be adequately protected (Trout and Schulte [@CR153]). For many nanomaterials, the health endpoint of interest for medical surveillance is not known, and hence only generalized medical surveillance is warranted (NIOSH [@CR96]). However, as new information is generated, more specific guidance for medical surveillance will be developed and should be implemented, as was recommended for workers exposed to carbon nanotubes and nanofibers (NIOSH [@CR99], [@CR100]).

In addition to medical surveillance, the potential long-term health experience of workers exposed to nanomaterials needs to be assessed through epidemiologic research and workplace exposure characterization studies. This is a difficult challenge since the nanomaterial workforce is widely distributed, exposed to a large number of different materials, and the appropriate health endpoints have not yet been consistently defined (Schulte et al. [@CR142]; Riediker et al. [@CR124]). In the short-term, cross-sectional studies using biomarkers may be the best approach; ultimately prospective and retrospective cohort studies will be needed (Li and Nel [@CR70]; Liou et al. [@CR72]; Schulte and Trout [@CR139]; Riediker et al. [@CR124]). Additionally as more hazard information becomes available, it may be useful to consider the value of registries of exposed workers in various sectors (Boutou-Kempf et al. [@CR15]; Schulte et al. [@CR144]). Such registries would allow more efficient identification of larger study populations, and may reduce the burden of epidemiology studies in the workplace.

Worker training is a key component in risk management and an indicator of responsible development of any technology (Kulinowski and Lippy [@CR68]; Ponce del Castillo [@CR120]). Although control of workplace exposures is the responsibility of the employer, training workers is integral to risk communication and management. Employers must train workers on workplace hazards and job tasks that may expose them to nanomaterials; on routes of exposure and methods used for controlling exposures; and on the use of respiratory protection and good work practices. Workers should also be informed about the potential health risks from exposure to nanomaterials and the possible need for medical surveillance (NIOSH [@CR96]). If nanotechnology is to be responsibly developed, worker protection has to be woven into codes of conduct, corporate responsibility pronouncements, and third-party certification schemes. Examples of such proactive efforts have illustrated how they can lead to worker protection (Nano Risk Framework [@CR85]; Nanocyl [@CR86]; Luigi [@CR73]; BASF [@CR7]; IG-DHS [@CR54]; TÜV SÜD Industrie Service GmbH [@CR154]; Verband der Chemischen Industrie [@CR158]).

Continued dialog on risk management between nations and among stakeholders is needed. The international dialog on responsible research and development of nanotechnology is a firm foundation on which to build this dialog (Tomellini and Giordani [@CR152]). Critical to the implementation of good risk management practices is the need to form partnerships among stakeholders to achieve common approaches to perceiving and controlling risks. Engaged stakeholders---such as corporations, trade associations, unions, nongovernmental organizations, insurance organizations, scientists, academic organizations, and government agencies---need to advocate for responsible development, and particularly for worker protection from potential adverse effects of nanomaterials.

Foster the safe development of nanotechnology and the realization of its societal and commercial benefits {#Sec7}
---------------------------------------------------------------------------------------------------------

At the societal level, responsible development of nanotechnology can provide benefits to workers and the rest of the population (Fig. [2](#Fig2){ref-type="fig"}) (Roco et al. [@CR128]). Both the general population and the nanomaterial workforce may benefit from the diffusion of nanotechnology and nanoscience, but social and commercial benefits do not take precedence over worker safety and health. As part of the general population, workers can receive the projected societal benefits of nanotechnology (Roco [@CR125]). These benefits may include good high paying jobs, and innovative products that address critical societal problems in materials, health, transportation, energy, and pollution. In addition to those societal gains, the workforce also benefits from nanotechnology research where nanotechnology-enabled products, such as nanotechnology-enabled sensors for detecting hazardous agents, nano-enhanced protection equipment, and nanomaterials, that are safer than traditional chemicals, have been developed to help ensure a safe work place. When workers are protected, the entire population benefits, because workers are part of it, and burdens on the population resulting from lack of protection are minimized. Others in the population are more receptive to new technologies when they see that precautions are taken, and workers are not harmed by nanomaterials (Hansen et al. [@CR43]; Pidgeon et al. [@CR119]; Savolainen [@CR134]). Conversely, if the population sees that workers are harmed by nanomaterials, then it will be more resistant to products containing nanomaterials. Critical in this dynamic is the level of knowledge and certainty about protection and harm. Consequently, if employers, government agencies, or scientists are not clear in communicating the level of uncertainty about hazards and risks, or if they over-depict or under-depict those hazards and risks, then this may lead to an adverse reaction toward nanotechnology by the general population (Berube [@CR12]; Tannert et al. [@CR151]). If employers' or authorities' investments to address uncertainty are not adequate or timely, then this too can impede the development of the technology (Hansen et al. [@CR43]; Forloni [@CR39]). All of these aspects are components of building trust, which is critical to public engagement (Tannert et al. [@CR151]; Berube et al. [@CR13]).Fig. 2Pathways for responsible development of nanotechnology

Although avoiding hyperbole about hazards, risks, and benefits is important, it does not mean that in the face of uncertainty, immutable precautionary measures must be instituted. Rather, strict precautionary measures should be implemented when high levels of uncertainty about the potential health risk exist and then be modified as more scientific information becomes available.

If nanotechnology is to be fostered and its benefits realized, there is need to show that any health risks associated with exposure to nanomaterials can be minimized. A classic pitfall is the premise that putting one part of the population at risk can inversely provide a benefit to others (e.g., workers needlessly exposed to cotton dust in the production of cotton textile products) (American Textile Manufacturers Institute Inc. et al. versus Donovan, Secretary of Labor et al. [@CR165]). This is contrary to the law and ethical presumptions in the United States and elsewhere. Maintaining the health and safety of the workforce while promoting development of nanotechnology can be in conflict and this must be guarded against, but since the two are linked, this linkage is promoted as an important criterion for responsible development. There cannot be responsible development of nanotechnology if workers are harmed.

The successful realization of the benefits of nanotechnology will be based, in part, on the public perception of risks and opinions of whether risk concerns are being addressed (Pidgeon et al. [@CR119]). Although risk perception research focuses on "social risk phenomena" that are not covered in traditional risk assessment, such research needs to be an integral part of the effort in determining how the public reacts to workers' risks and the efforts to control them (Harthorn [@CR44]). It also should be noted that responsible development of nanotechnology involves many other factors, and ethical issues that are not derivative of worker risks (Alloff and Lin [@CR3]).

Another aspect of responsible development of nanotechnology is the need to support research over the total life cycle of nanomaterials, so that occupational exposure to nanomaterials may not also lead to environmental exposures (Beaudrie et al. [@CR11]). This life cycle focus may be an efficient use of resources and lead to a holistic assessment of the impact on people, organisms, and ecosystems (Karn and Bergeson [@CR63]). Designing out the hazardous properties in nanomaterials may be a solution.

Responsible development of nanotechnology requires that society understand complex issues of hazard, exposure, dose, risk, and control as well as the potential for impact of nanotechnology on labor markets (Harthorn [@CR44]; Pidgeon et al. [@CR119]; Invernizzi [@CR56]). This calls for achieving and maintaining a heightened level of scientific literacy and engagement (Bauer [@CR9]). This will require continued and enhanced investment in education, training, and awareness across all ages and socioeconomic levels, including both workers and the general population, and it may be best to start with or include the K-12 population. The investment in education can also stimulate new generations of scientists to work on optimizing the benefits of nanotechnology.

Further, these efforts to protect workers and foster the benefits of nanotechnology must be based on a global vision, since the development, manufacture, and use of nanomaterials will be globally, albeit not evenly, distributed. Common global understanding of the elements of responsible development of nanotechnology is needed.

Extent of compliance with precautionary guidance {#Sec8}
================================================

In these opening decades of commercial nanotechnology, there are many examples showing that the principles and practices of responsible development have enjoyed broad support (Tomellini and Giordani [@CR152]; NNI [@CR102]; Forloni [@CR39]; BIAC [@CR20]). However, it is not clear to what extent precautionary guidance is being followed. This needs to be assessed on a national and global basis. Preliminary investigations have been a good start, but reflect small response rates and potential volunteer bias (ICON [@CR55]; Engeman et al. [@CR34]). More detailed and rigorous evaluations are required to minimize such bias. Plans are under way to develop such evaluations, but these efforts are expensive, and it will be difficult to identify and access employers and workplaces (Schulte and Iavicoli [@CR136]; 78 Federal Register [@CR1]). Business, government, labor, and other organizations must invest in developing and coordinating such evaluations. Assessing the extent to which there is compliance with precautionary guidance to protect workers involved with nanomaterials is a critical benchmark of responsible development of nanotechnology. Additionally, after such an evaluation is conducted, it will be important to identify hot spots, i.e., sectors, subsectors, and types of establishments or enterprises where compliance is less than appropriate and then institute remediation and strategic intervention (such as information campaigns).

Conclusion {#Sec9}
==========

If the kinds of problems that have plagued previous emergent technologies are to be avoided, criteria are needed to define the responsible development of nanotechnology. The cornerstone of responsible development is the duty to protect workers, who are the first people exposed to the potential hazards of the technology. Protecting consumers and the environment are also important, but the foundation of responsible development begins with worker protection. However, these are not unrelated efforts. This article identifies five criterion actions that together can ensure responsible development of nanotechnology. All of these criteria are necessary components, and they need to be integrated with each other in practice, so that the knowledge gained through their implementation helps to advance the benefits of this technology. If these criteria are to be of value and applied, corporate and political support, globally, will be required. A lack of such support could pose a risk of harm to workers and could result in societal resistance to the development of nanotechnology.

The authors thank the following for comments on earlier drafts: Sheldon Samuels, Gregory Wagner, Knut Ringen, Ivo Iavicoli, Janet Carter, and Patricia Sullivan. The findings and conclusions of this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health.
